Aerin Medical reports new results from RHINTRAC trial of RhinAer technology
RhinAer is a temperature-controlled radiofrequency technology to directly interrupt posterior nasal nerve signals and help reduce chronic rhinitis…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Jul 22
RhinAer is a temperature-controlled radiofrequency technology to directly interrupt posterior nasal nerve signals and help reduce chronic rhinitis…
30 Jun 22
The study published in the International Forum of Allergy & Rhinology shows that the durability of the VivAer…
22 Jun 22
Envoy Medical’s single-centre early feasibility study of Acclaim cochlear implant will take place at Mayo Clinic in Rochester,…
08 Jun 22
RhinAer treatment resulted in significant symptom improvement through 24 months in both non-allergic and allergic rhinitis patients
03 Jun 22
AuriNovo is a 3D-bioprinted implant that was developed utilising a patented technology that used the patient's own tissue…
04 May 22
The researchers at Birmingham Women’s and Children’s NHS Foundation Trust developed the non-invasive prenatal diagnosis test to identify…
04 Apr 22
The test takes 25 minutes to determine if a critically ill new-born admitted to intensive care has a…
31 Mar 22
The device will enhance patient access and communication between patients and ophthalmologists, collect data, and serve as a…
14 Mar 22
Data continue to show potential of ProSomnus’s patient-preferred oral appliance therapy devices to treat obstructive sleep apnea
01 Mar 22
With a flexible balloon section that facilitates patient-specific placement based on their individual anatomy, the US Food and…